Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations

Carcinogenesis

Volumn 27, Issue 3, 2006, Pages 392-404

  Kim, Il Jin ^a   Kang, Hio Chung ^a,b   Jang, Sang Geun ^a   Kim, Kun ^a   Ahn, Sun A ^a   Yoon, Hyun Ju ^a   Yoon, Sang Nam ^c   Park, Jae Gahb ^a,b,c  

^a Seoul National University   (South Korea)

^b National Cancer Center   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; B RAF KINASE; K RAS PROTEIN; PROTEIN P53; RAF PROTEIN;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLUSTER ANALYSIS; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; MULTIDIMENSIONAL SCALING; MUTANT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; GENES, RAS; HUMANS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 33644863904     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi237     Document Type: Article

References (54)

1. Shin, H.R., Jung, K.W., Won, Y.J. and Park, J.G. (2004) 2002 Annual report of the Korea Central Cancer Registry: Based on registered data from 139 hospitals. Cancer Res. Treat., 36, 103-114.
2. Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
3. Forrester,K., Almoguera,C., Han,K., Grizzle,W.E. and Perucho,M. (1987) Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature, 327, 298-303.
4. Rodrigues,N.R., Rowan,A., Smith,M.E., Kerr,I.B., Bodmer,W.F., Gannon,J.V. and Lane,D.P. (1990) p53 mutations in colorectal cancer. Proc. Natl Acad. Sci. USA, 87, 7555-7559.
5. Miyoshi,Y., Nagase,H., Ando,H., Horii,A., Ichii,S., Nakatsuru,S., Aoki,T., Miki,Y., Mori,T. and Nakamura,Y. (1992) Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene. Hum. Mol. Genet., 1, 229-233.
6. Fishel,R., Lescoe,M.K., Rao,M.R., Copeland,N.G., Jenkins,N.A., Garber,J., Kane,M. and Kolodner,R. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75, 1027-1038.
7. Bronner,C.E., Baker,S.M., Morrison,P.T. et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 368, 258-261.
8. Kim,I.J., Kang,H.C., Park,J.H., Shin,Y., Ku,J.L., Lim,S.B., Park,S.Y., Jung,S.Y., Kim,H.K. and Park,J.G. (2003) Development and applications of a beta-catenin oligonucleotide microarray: Beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. Clin. Cancer Res., 9, 2920-2925.
9. Park,J.H., Kim,I.J., Kang,H.C., Shin,Y., Park,H.W., Jang,S.G., Ku,J.L., Lim,S.B., Jeong,S.Y. and Park,J.G. (2004) Oligonucleotide microarray-based mutation detection of the K-ras gene in colorectal cancers with use of competitive DNA hybridization. Clin. Chem., 50, 1688-1691.
10. Davies,H., Bignell,G.R., Cox,C. et al. (2002) Mutations of the BRAF gene in human cancer. Nature, 417, 949-954.
11. Yuen,S.T., Davies,H., Chan,T.L. et al. (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res., 62, 6451-6455.
12. Rajagopalan,H., Bardelli,A., Lengauer,C., Kinzler,K.W., Vogelstein,B. and Velculescu,V.E. (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature, 418, 934.
13. Kolch,W. (2000) Meaningful relationships: The regulation of the Ras/Raf/ MEK/ERK pathway by protein interactions. Biochem, J., 351, 289-305.
14. Pollock,P.M., Harper,U.L., Hansen,K.S. et al. (2003) High frequency of BRAF mutations in nevi. Nat. Genet., 33, 19-20.
15. Singer,G., Oldt,R.,III, Cohen,Y., Wang,B.G., Sidransky,D., Kurman,R.J. and Shih,IeM. (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J. Natl Cancer Inst., 95, 484-486.
16. Kim,I.J., Park,J.H., Kang,H.C., Shin,Y., Park,H.W., Park,H.R., Ku,J.L., Lim,S.B. and Park,J.G. (2003) Mutational analysis of BRAF and K-ras in gastric cancers: Absence of BRAF mutations in gastric cancers. Hum. Genet., 114, 118-120.
17. Wang,L., Cunningham,J.M., Winters,J.L. et al. (2003) BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res., 63, 5209-5212.
18. Domingo,E., Laiho,P., Ollikainen,M. et al. (2004) BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J. Med. Genet., 41, 664-668.
19. Deng,G., Bell,I., Crawley,S., Gum,J., Terdiman,J.P., Allen,B.A., Truta,B., Sleisenger,M.H. and Kim,Y.S. (2004) BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin. Cancer Res., 10, 191-195.
20. Nagasaka,T., Sasamoto,H., Notohara,K. et al. (2004) Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J. Clin. Oncol., 22, 4584-4594.
21. Kumar,R., Angelini,S., Czene,K., Sauroja,I., Hahka-Kemppinen,M., Pyrhonen,S. and Hemminki,K. (2003) BRAF mutations in metastatic melanoma: A possible association with clinical outcome. Clin. Cancer Res., 9, 3362-3368.
22. Peggs,K. (2004) Imatinib mesylate -gold standards and silver linings. Clin. Exp. Med., 4, 1-9.
23. Cripps,M.C., Figueredo,A.T., Oza,A.M., Taylor,M.J., Fields,A.L., Holmlund,J.T., McIntosh,L.W., Geary,R.S. and Eisenhauer,E.A. (2002) Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: A National Cancer Institute of Canada clinical trials group study. Clin. Cancer Res., 8, 2188-2192.
24. Coudert,B., Anthoney,A., Fiedler,W. et al. (2001) Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report. Eur. J. Cancer, 37, 2194-2198.
25. Schena,M., Shalon,D., Davis,R.W. and Brown,P.O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 270, 467-470.
26. DeRisi,J., Penland,L., Brown,P.O., Bittner,M.L., Meltzer,P.S., Ray,M., Chen,Y., Su,Y.A. and Trent,J.M. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet., 14, 457-460.
27. Ramaswamy,S. and Golub,T.R. (2002) DNA microarrays in clinical oncology. J. Clin. Oncol., 20, 1932-1941.
28. Golub,T.R., Slonim,D.K., Tamayo,P. et al. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.
29. Kitahara,O., Katagiri,T., Tsunoda,T., Harima,Y. and Nakamura,Y. (2002) Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia, 4, 295-303.
30. Mariadason,J.M., Arango,D., Shi,Q., Wilson,A.J., Comer,G.A., Nicholas,C., Aranes,M.J., Lesser,M., Schwartz,E.L. and Augenlicht,L.H. (2003) Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res., 63, 8791-8812.
31. Hedenfalk,I., Duggan,D., Chen,Y. et al. (2001) Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med., 344, 539-548.
32. Hedenfalk,I., Ringner,M., Ben-Dor,A. et al. (2003) Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc. Natl Acad. Sci. USA, 100, 2532-2537.
33. Dunican,D.S., McWilliam,P., Tighe,O., Parle-McDermott,A. and Croke,D.T. (2002) Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization. Oncogene, 21, 3253-3257.
34. Pavey,S., Johansson,P., Packer,L. et al. (2004) Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene, 23, 4060-4067.
35. Won,Y.J., Park,K.J., Kwon,H.J., Lee,J.H., Kim,J.H., Kim,Y.J., Chun,S.H., Han,H.J. and Park,J.G. (1999) Germline mutations of the APC gene in Korean familial adenomatous polyposis patients. J. Hum. Genet., 44, 103-108.
36. Bakkar,A.A., Wallerand,H., Radvanyi,F. et al. (2003) FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Res., 63, 8108-8112.
37. Kim,I.J., Kang,H.C., Shin,Y. et al. (2004) A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome. J. Hum. Genet., 49, 591-595.
38. Kim,I.J., Shin,Y., Kang,H.C. et al. (2003) Robust microsatellite instability (MSI) analysis by denaturing high-performance liquid chromatography (DHPLC). J. Hum. Genet., 48, 525-530.
39. Kang,H.C., Kim,I.J., Park,J.H., Shin,Y., Ku,J.L., Jung,M.S., Yoo,B.C., Kim,H.K. and Park,J.G. (2004) Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin. Cancer Res., 10, 272-284.
40. Eisen,M.B., Spellman,P.T., Brown,P.O. and Botstein,D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA, 95, 14863-14868.
41. Korkola,J.E., DeVries,S., Fridlyand,J., Hwang,E.S., Estep,A.L., Chen,Y.Y., Chew,K.L., Dairkee,S.H., Jensen,R.M. and Waldman,F.M. (2003) Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res., 63, 7167-7175.
42. Zhao,W., Chan,T.L., Chu,K.M., Chan,A.S., Stratton,M.R., Yuen,S.T. and Leung,S.Y. (2004) Mutations of BRAF and KRAS in gastric cancer and their association with microsatellite instability. Int. J. Cancer, 108, 167-169.
43. Ikenoue,T., Hikiba,Y., Kanai,F. et al. (2004) Rapid detection of mutations in the BRAF gene using real-time polymerase chain reaction and melting curve analysis. Cancer Genet. Cytogenet., 149, 68-71.
44. Mori,Y., Selaru,F.M., Sato,F. et al. (2003) The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Res., 63, 4577-4582.
45. Lev,D.C., Onn,A., Mehnkova,V.O., Miller,C., Stone,V., Ruiz,M., McGary,E.C., Ananthaswamy,H.N., Price,J.E. and Bar-Eli,M. (2004) Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. J. Clin. Oncol., 22, 2092-2100.
46. Knall,C., Young,S., Nick,J.A., Buhl,A.M., Worthen,G.S. and Johnson,G.L. (1996) Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem., 271, 2832-2838.
47. Sparmann,A. and Bar-Sagi,D. (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell, 6, 447-458.
48. Banerjea,A., Ahmed,S., Hands,R.E., Huang,F., Han,X., Shaw,P.M., Feakins,R., Bustin,S.A. and Dorudi,S. (2004) Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol. Cancer, 3, 21.
49. Miyoshi,K., Wakioka,T., Nishinakamura,H., Kamio,M., Yang,L., Inoue,M., Hasegawa,M., Yonemitsu,Y., Komiya,S. and Yoshimura,A. (2004) The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization. Oncogene, 23, 5567-5576.
50. Wakioka,T., Sasaki,A., Kato,R., Shouda,T., Matsumoto,A., Miyoshi,K., Tsuneoka,M., Komiya,S., Baron,R. and Yoshimura,A. (2001) Spred is a Sprouty-related suppressor of Ras signalling. Nature, 412, 647-651.
51. Huntington,J.T., Shields,J.M., Der,C.J., Wyatt,C.A., Benbow,U., Slingluff,C.L.Jr and Brinckerhoff,C.E. (2004) Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: Role of BRAF mutation and fibroblast growth factor signaling. J. Biol. Chem., 279, 33168-33176.
52. Roy,M., Li,Z. and Sacks,D.B. (2004) IQGAP1 binds ERK2 and modulates its activity. J. Biol. Chem., 279, 17329-17337.
53. Kim,J., Nueda,A., Meng,Y.H., Dynan,W.S., Mivechi,N.F. (1997) Analysis of the phosphorylation of human heat shock transcription factor-1 by MAP kinase family members. J. Cell Biochem., 67, 43-54.
54. Magdinier, F. and Wolffe, A.P. (2001) Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl Acad. Sci. USA, 98, 4990-4995.